Evidence map›Paper›PMID 30373771›Full record

ArticleThe Journal of biological chemistry2019

Discovery of peptide ligands targeting a specific ubiquitin-like domain-binding site in the deubiquitinase USP11.

Anastasios Spiliotopoulos, Lia Blokpoel Ferreras, Ruth M Densham, Simon G Caulton, Ben C Maddison, Joanna R Morris, James E Dixon, Kevin C Gough, Ingrid Dreveny

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Enhanced localized pressure-mediated non-viral gene delivery.Drug delivery and translational research · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Next-Generation Phage Display to Identify Peptide Ligands of Deubiquitinases.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  8. Article
  9. Binding of Vialinin A andMolecules (Basel, Switzerland) · 2022
    Article
  10. Review
  11. The Dual Role of USP11 in Cancer.Journal of oncology · 2022
    Review
  12. Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.Frontiers in cell and developmental biology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Genetically-programmed, mesenchymal stromal cell-laden & mechanically strong 3D bioprinted scaffolds for bone repair.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  19. Article
  20. Small molecules that target the ubiquitin system.Biochemical Society transactions · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Anastasios SpiliotopoulosFrom the Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD.
Lia Blokpoel FerrerasFrom the Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD.
Ruth M Denshamthe Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham B15 2TT, and.
Simon G CaultonFrom the Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD.
Ben C MaddisonADAS, School of Veterinary Medicine and Science, Bonington Campus, College Road, Sutton Bonington, Leicestershire LE12 5RD, United Kingdom.
Joanna R Morristhe Birmingham Centre for Genome Biology and Institute of Cancer and Genomic Sciences, Medical and Dental Schools, University of Birmingham, Birmingham B15 2TT, and.
James E DixonFrom the Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD.
Kevin C Goughthe School of Veterinary Medicine and Science, Sutton Bonington Campus, College Road, Sutton Bonington, Leicestershire LE12 5RD, kevin.gough@nottingham.ac.uk.ORCID 0000-0001-5211-2088
Ingrid DrevenyFrom the Centre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, ingrid.dreveny@nottingham.ac.uk.ORCID 0000-0003-2256-642X
University of Nottingham · GBUniversity of Birmingham · GBSutton Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H012656/1Cancer Research UK 19062Cancer Research UK C8820/A19062
6 · The paper itself

Abstract

Ubiquitin-specific proteases (USPs) reverse ubiquitination and regulate virtually all cellular processes. Defined noncatalytic domains in USP4 and USP15 are known to interact with E3 ligases and substrate recruitment factors. No such interactions have been reported for these domains in the paralog USP11, a key regulator of DNA double-strand break repair by homologous recombination. We hypothesized that USP11 domains adjacent to its protease domain harbor unique peptide-binding sites. Here, using a next-generation phage display (NGPD) strategy, combining phage display library screening with next-generation sequencing, we discovered unique USP11-interacting peptide motifs. Isothermal titration calorimetry disclosed that the highest affinity peptides (

Indexed as

Amino Acid SequenceAnimalsBinding SitesCell LineCrystallography, X-RayDNA RepairHomologous RecombinationHumansKineticsLigandsMiceMolecular Sequence DataPeptidesProtein DomainsThiolester HydrolasesUbiquitinLigandsPeptidesThiolester HydrolasesUbiquitinUSP11 protein, humancell-penetrating peptide (CPP)crystal structuredeubiquitylation (deubiquitination)DNA damage responsemolecular recognitionpeptide interactionpeptidesphage displayproteaseubiquitinubiquitin-dependent proteaseUSP11

Identifiers

PMID30373771
PMCPMC6333900
OpenAlexW2899455321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.